TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY

81796130 ABSTRACT Compounds of formula (IIA) or N-oxides thereof, or pharmaceutically acceptable salts or solvates thereof, or co-crystals thereof: ,3 IC-N/\-N 1 Q-Z R11/\/---N \ E 16 R15 (IIA) being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevent...

Full description

Saved in:
Bibliographic Details
Main Authors LOWE, MARTIN ALEXANDER, JACKSON, VICTORIA ELIZABETH, PORTER, JOHN ROBERT, KROEPLIEN, BORIS
Format Patent
LanguageEnglish
French
Published 18.01.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:81796130 ABSTRACT Compounds of formula (IIA) or N-oxides thereof, or pharmaceutically acceptable salts or solvates thereof, or co-crystals thereof: ,3 IC-N/\-N 1 Q-Z R11/\/---N \ E 16 R15 (IIA) being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. Date Recue/Date Received 2021-05-03 La présente invention concerne une série de dérivés de 4,5,6,7-tétrahydro-1H-imidazo[4,5-c]pyridine substitués, puissant modulateurs de l'activité du TNF-a humain, qui sont donc utiles dans le traitement et/ou la prévention de diverses maladies humaines, notamment les troubles auto-immuns et inflammatoires, les troubles neurologiques et neurodégénératifs, les troubles nociceptifs et de la douleur, les troubles cardiovasculaires, les troubles métaboliques, les troubles oculaires et les troubles oncologiques.
Bibliography:Application Number: CA20142930757